Pakistan - Medicaments of Antibiotics other than Penicillins, Streptomycins or their Derivatives - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingPakistan: Market for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives 2024
Market Size for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Pakistan
The Pakistani market for medicaments of antibiotics other than penicillins, streptomycins or their derivatives declined to $X in 2023, reducing by X% against the previous year. In general, the total consumption indicated a mild increase from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption decreased by X% against 2020 indices. As a result, consumption reached the peak level of $X. From 2016 to 2023, the growth of the market failed to regain momentum.
Production of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Pakistan
In value terms, non-penicillin or streptomycin antibiotic medicaments production dropped to $X in 2023 estimated in export price. Over the period under review, the total production indicated a moderate expansion from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2020 indices. The pace of growth appeared the most rapid in 2019 with an increase of X%. Non-penicillin or streptomycin antibiotic medicaments production peaked at $X in 2015; however, from 2016 to 2023, production remained at a lower figure.
Exports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives
Exports from Pakistan
In 2023, approx. X tons of medicaments of antibiotics other than penicillins, streptomycins or their derivatives were exported from Pakistan; growing by X% against the previous year's figure. Overall, exports showed strong growth. As a result, the exports reached the peak and are likely to continue growth in the immediate term.
In value terms, non-penicillin or streptomycin antibiotic medicaments exports skyrocketed to $X in 2023. In general, exports showed a mild expansion. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. As a result, the exports attained the peak of $X. From 2022 to 2023, the growth of the exports remained at a somewhat lower figure.
Exports by Country
The Philippines (X tons), Nigeria (X tons) and Kenya (X tons) were the main destinations of non-penicillin or streptomycin antibiotic medicaments exports from Pakistan, with a combined X% share of total exports. Singapore, Sri Lanka, Maldives, Thailand, Fiji, Afghanistan, Sierra Leone, Ghana, the United Arab Emirates and France lagged somewhat behind, together accounting for a further X%.
From 2012 to 2023, the biggest increases were recorded for the United Arab Emirates (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.
In value terms, the largest markets for non-penicillin or streptomycin antibiotic medicaments exported from Pakistan were Nigeria ($X), Sri Lanka ($X) and the Philippines ($X), with a combined X% share of total exports. Kenya, Singapore, Maldives, Thailand, Afghanistan, Sierra Leone, Fiji, France, Ghana and the United Arab Emirates lagged somewhat behind, together accounting for a further X%.
The United Arab Emirates, with a CAGR of X%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
In 2023, the average export price for medicaments of antibiotics other than penicillins, streptomycins or their derivatives amounted to $X per ton, reducing by X% against the previous year. Overall, the export price recorded a abrupt contraction. The growth pace was the most rapid in 2019 when the average export price increased by X%. Over the period under review, the average export prices attained the maximum at $X per ton in 2016; however, from 2017 to 2023, the export prices remained at a lower figure.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Sri Lanka ($X per ton), while the average price for exports to the Philippines ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to Sri Lanka (X%), while the prices for the other major destinations experienced a decline.
Imports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives
Imports into Pakistan
In 2023, the amount of medicaments of antibiotics other than penicillins, streptomycins or their derivatives imported into Pakistan soared to X tons, with an increase of X% compared with 2022 figures. Over the period under review, imports, however, recorded a slight decrease. The pace of growth appeared the most rapid in 2020 when imports increased by X%. Imports peaked at X tons in 2017; however, from 2018 to 2023, imports stood at a somewhat lower figure.
In value terms, non-penicillin or streptomycin antibiotic medicaments imports fell dramatically to $X in 2023. Overall, imports, however, saw a pronounced setback. The pace of growth was the most pronounced in 2017 with an increase of X% against the previous year. As a result, imports attained the peak of $X. From 2018 to 2023, the growth of imports remained at a lower figure.
Imports by Country
In 2023, China (X tons) constituted the largest non-penicillin or streptomycin antibiotic medicaments supplier to Pakistan, accounting for a X% share of total imports. Moreover, non-penicillin or streptomycin antibiotic medicaments imports from China exceeded the figures recorded by the second-largest supplier, South Korea (X tons), fivefold. Switzerland (X tons) ranked third in terms of total imports with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of volume from China amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: South Korea (X% per year) and Switzerland (X% per year).
In value terms, China ($X) constituted the largest supplier of medicaments of antibiotics other than penicillins, streptomycins or their derivatives to Pakistan, comprising X% of total imports. The second position in the ranking was held by Switzerland ($X), with a X% share of total imports. It was followed by South Korea, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value from China was relatively modest. The remaining supplying countries recorded the following average annual rates of imports growth: Switzerland (X% per year) and South Korea (X% per year).
Import Prices by Country
The average import price for medicaments of antibiotics other than penicillins, streptomycins or their derivatives stood at $X per ton in 2023, falling by X% against the previous year. Overall, the import price showed a perceptible slump. The pace of growth was the most pronounced in 2013 when the average import price increased by X% against the previous year. Over the period under review, average import prices reached the peak figure at $X per ton in 2019; however, from 2020 to 2023, import prices failed to regain momentum.
There were significant differences in the average prices amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was Ireland ($X per ton), while the price for China ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Jordan (X%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Pakistan. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201150 - Medicaments of other antibiotics, n.p.r.s.
- Prodcom 21201180 - Medicaments of other antibiotics, p.r.s.
Country coverage:
- Pakistan
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Pakistan
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Asia.
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in the U.S..
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in China.
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in the EU.
This report provides an in-depth analysis of the global market for non-penicillin or streptomycin antibiotic medicaments.
- Price for Medicaments of Other Antibiotics Pakistan
- Non-Penicillin or Streptomycin Antibiotic Medicaments Market
- Hormones Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Sterile Medical Adhesion Barrier Market
- Human and Animal Blood Market